Manns M, Steinbach B, Polaschegg HD, Schlaeper C, Evering HG
A new technological approach to CRRT in acute renal
failure
23rd ESAO Congress, Warsaw
Int J Artif Organs
(Sep) 10:560 1996
This is a preliminary report of new technology being developed for
CRRT. The blood pump is replaced by a pneumatic pump, and there is no
venous drip chamber; the latter is replaced by two hydrophobic, air
separating membranes at the blood pump and venous line. The idea is,
that there is less trauma to blood elements and no exposure to an air-
blood interface, both of which may increase the risk of clotting.
There is no patient data using the device as yet, but as
Fresenius is behind the technology, it certainly is an area that bears
watching. Clotting remains a major problem in CRRT, and if the new
technology could minimize the incidence of clotting by avoidance of
the air-blood interface, this would be a significant advance. Of
course the advantages remain to be demonstrated in a properly
controlled clinical trial. (John T. Daugirdas, M.D., University of
Illinois at Chicago)
To go back use the BACK button on your browser.
Otherwise click on the desired link to this article below:
23rd ESAO Congress, Warsaw
Other extracorporeal therapies :
Continous therapies